$2.3T
Total marketcap
$103.65B
Total volume
BTC 49.78%     ETH 15.56%
Dominance

Neogen Corporation NG2.F Stock

11.9 EUR {{ price }} 4.385965% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
2.58B EUR
LOW - HIGH [24H]
11.9 - 11.9 EUR
VOLUME [24H]
20 EUR
{{ volume }}
P/E Ratio
595.00
Earnings per share
0.02 EUR

Neogen Corporation Price Chart

Neogen Corporation NG2.F Financial and Trading Overview

Neogen Corporation stock price 11.9 EUR
Previous Close 17.7 EUR
Open 17.9 EUR
Bid 17.9 EUR x 40000
Ask 18.4 EUR x 40000
Day's Range 17.9 - 17.9 EUR
52 Week Range 10.8 - 23.6 EUR
Volume 20 EUR
Avg. Volume 8 EUR
Market Cap 3.87B EUR
Beta (5Y Monthly) 0.988028
PE Ratio (TTM) N/A
EPS (TTM) 0.02 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 55 EUR

NG2.F Valuation Measures

Enterprise Value 4.62B EUR
Trailing P/E N/A
Forward P/E 23.866667
PEG Ratio (5 yr expected) 6.74
Price/Sales (ttm) 5.3700495
Price/Book (mrq) 1.2383258
Enterprise Value/Revenue 6.409
Enterprise Value/EBITDA 37.4

Trading Information

Neogen Corporation Stock Price History

Beta (5Y Monthly) 0.988028
52-Week Change -19.19%
S&P500 52-Week Change 20.43%
52 Week High 23.6 EUR
52 Week Low 10.8 EUR
50-Day Moving Average 15.8 EUR
200-Day Moving Average 15.8 EUR

NG2.F Share Statistics

Avg. Volume (3 month) 8 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 216.22M
Float 216.01M
Short Ratio N/A
% Held by Insiders 0.076%
% Held by Institutions 101.13%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends May 31, 2022
Most Recent Quarter (mrq) February 28, 2023
Next Fiscal Year End May 31, 2023

Profitability

Profit Margin -1.87%
Operating Margin (ttm) 8.00%
Gross Margin 48.25%
EBITDA Margin 17.13%

Management Effectiveness

Return on Assets (ttm) 1.31%
Return on Equity (ttm) -0.67%

Income Statement

Revenue (ttm) 720.73M EUR
Revenue Per Share (ttm) 4.46 EUR
Quarterly Revenue Growth (yoy) 70.19%
Gross Profit (ttm) 243.01M EUR
EBITDA 123.52M EUR
Net Income Avi to Common (ttm) -13483000 EUR
Diluted EPS (ttm) -0.02
Quarterly Earnings Growth (yoy) 50.50%

Balance Sheet

Total Cash (mrq) 185.9M EUR
Total Cash Per Share (mrq) 0.86 EUR
Total Debt (mrq) 891.79M EUR
Total Debt/Equity (mrq) 28.53 EUR
Current Ratio (mrq) 5.183
Book Value Per Share (mrq) 14.455

Cash Flow Statement

Operating Cash Flow (ttm) -29548000 EUR
Levered Free Cash Flow (ttm) -60182876 EUR

Profile of Neogen Corporation

Country Germany
State MI
City Lansing
Address 620 Lesher Place
ZIP 48912
Phone 517 372 9200
Website https://www.neogen.com
Industry Diagnostics & Research
Sector(s) Healthcare
Full Time Employees 2108

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Q&A For Neogen Corporation Stock

What is a current NG2.F stock price?

Neogen Corporation NG2.F stock price today per share is 11.9 EUR.

How to purchase Neogen Corporation stock?

You can buy NG2.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Neogen Corporation?

The stock symbol or ticker of Neogen Corporation is NG2.F.

Which industry does the Neogen Corporation company belong to?

The Neogen Corporation industry is Diagnostics & Research.

How many shares does Neogen Corporation have in circulation?

The max supply of Neogen Corporation shares is 216.61M.

What is Neogen Corporation Price to Earnings Ratio (PE Ratio)?

Neogen Corporation PE Ratio is 595.00000000 now.

What was Neogen Corporation earnings per share over the trailing 12 months (TTM)?

Neogen Corporation EPS is 0.02 EUR over the trailing 12 months.

Which sector does the Neogen Corporation company belong to?

The Neogen Corporation sector is Healthcare.